iodine
The Critical Minerals Report (12.07.2025): How Washington, Brussels, London, and Beijing Are Rewiring the Critical Minerals Supply Chains
From Saturday, November 22nd through this weekend, the critical minerals story has been less about prices and more…
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
-
Voyageur Prepares to Launch SmoothX™ Barium Sulfate CT Contrast Media
The contrast media market is a large global market valued at $4.7 billion and is forecasted to grow…
No CommentsInvestorNews
-
Offering freedom from China on Foreign Medical Imaging Supplies, Voyageur Pharmaceuticals announces another key milestone
Barium and iodine-based radiographic contrast media (RCM) are types of RCM used in diagnostic imaging. Both work by…
No CommentsInvestorNews
-
Voyageur’s quest to become the only fully integrated company in the radiographic contrast media field accelerates timeline with design of a carbon neutral pharmaceutical plant
Did you know that when you go to the doctor and require an X-Ray or scan in many…
1 CommentTracy Hughes
-
Brent Willis of Voyageur Pharmaceuticals on securing a domestic medical imaging agent supply
In this InvestorIntel interview with host Tracy Weslosky, Voyageur Pharmaceuticals Ltd.’s (TSXV: VM) President and CEO Brent Willis,…
3 CommentsInvestorNews
-
Voyageur Pharmaceuticals completes FDA submission milestone for first barium contrast product license application
Radiographic contrast media are substances used in diagnostic imaging tests such as ultrasound, X-rays, CT scans and MRI…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals’ Brent Willis on creating the first vertically integrated medical radiological contrast media supplier in NA
In a recent InvestorIntel interview, Tracy Weslosky spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd. (TSXV:…
No CommentsInvestorNews
-
Canada’s Voyageur Pharmaceuticals Breaking a Chinese Monopoly
In a recent InvestorIntel interview, Jack Lifton spoke with Brent Willis, President and CEO of Voyageur Pharmaceuticals Ltd.…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals strategy is to remove the middleman and supply radiographic contrast media direct from mine to the X-ray center
Sourcing raw materials is one of today’s biggest problems, as a result companies are looking to have more…
No CommentsInvestorNews
-
Voyageur Pharmaceuticals’ Supply Chain Security Advantage – From the Earth to the Bottle
With all the warnings issued in articles posted on InvestorIntel about rare earth supply security, the whole Suez…
No CommentsInvestorNews
Top 10 Trending
-
Critical Minerals Report (11.09.2025): Financing Critical Minerals 2.0 Through Government Equity and Private Capital
-
Congo, Cobalt and Children — A Tailings Dam Fails in Kolwezi
-
Critical Minerals Report (11.23.2025): A US$100 Billion Commitment Here, Another US$1.1 Billion There – How Government Capital Is Rewiring Critical Minerals Finance
InvestorNews Member News
-
Homerun Resources Inc. Announces Multi-Process Testing Results for Santa Maria Eterna High-Purity Silica Sand Project
-
Rockland Resources Arranges Financing
-
Appia Rare Earths & Uranium Corp. Issues Reminder for December 9, 2025 Presentation at the “John Tumazos Very Independent Research Conference”
-
Romios Proposes Name Change and Share Consolidation, Annual General and Special Meeting Scheduled for January 16, 2026
-
Coniagas Announces Amended and Restated LIFE Offering Document
